Bioventus Inc. Quarterly Deferred Income Tax Assets, Net in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Bioventus Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2020 to Q2 2024.
  • Bioventus Inc. Deferred Income Tax Assets, Net for the quarter ending June 29, 2024 was $6.88M.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.88M Jun 29, 2024 10-Q 2024-08-06
Q4 2023 $0 $0 Dec 31, 2023 10-Q 2024-08-06
Q4 2022 $0 -$481K -100% Dec 31, 2022 10-K 2023-03-31
Q3 2022 $0 -$481K -100% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 $0 -$481K -100% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 $0 -$481K -100% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 $481K +$481K Dec 31, 2021 10-K 2023-03-31
Q3 2021 $481K Oct 2, 2021 10-Q 2021-11-10
Q2 2021 $481K Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $481K Apr 3, 2021 10-Q 2021-05-13
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.